Likewise, Manic et al. [129] have demonstrated that the RAD51 inhibitor B02, along with the MRE11 inhibitor mirin, selectively kills the PARP1-upregulated CRC stem cells via mitotic catastrophe without the need for exposing cells to ATR/CHK1 inhibitors [129]. The gene discussed is CHEK1; the disease is colorectal carcinoma.